In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NaviGate Cardiac Structures, Inc.

Latest From NaviGate Cardiac Structures, Inc.

NaviGate Cardiac Structures Inc.

For patients with severe or irreversible moderate mitral regurgitation, NaviGate Cardiac Structures Inc. is developing a catheter-guided compressible valved stent that fits within the diseased mitral valve in a beating heart.

Medical Device

Start-Up Previews, January 2016

In this month's issue of Start-Up, we profile Alcresta Pharmaceuticals, Gordian Surgical, International Biomedical Devices, NaviGate Cardiac Structures, ObsEva and SweetBio.

BioPharmaceutical Medical Device

Case Study: Cross-Strait Agreement Could Shorten IND Timeframe For Products Entering China (Part 2 of 2)

Global pharmaceutical firms can look no further than across the Taiwan Strait when working to get products approved and launched in China faster.

BioPharmaceutical China

Australian biotechs fight over Progen

The Melbourne biotech firm Cytopia is challenging a merger between the Australian biotechs Progen Pharmaceuticals and Avexa, saying it can offer a better deal to Progen shareholders.

Infectious Diseases Cancer
See All

Company Information

  • Industry
  • Medical Devices
  • Other Names / Subsidiaries
    • NCSI